Christopher Paul German

Insider Reports History

Identity
Location
Boston, MA
SEC record
Reporting signature
/s/ Stephen Vander Stoep, attorney-in-fact for Christopher Paul German
SEC evidence
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Christopher Paul German:

Form 4 holding Corporate Controller & CAO

RHYTHM PHARMACEUTICALS, INC.

Security class
Restricted Stock Units
Shares / value
1,162
Estimated value
$120,201
Report date
01 Mar 2026
Price
$51.72
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Christopher Paul German

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .